Paper Details

  1. Home
  2. Paper Details

Triple versus dual inhaler therapy in moderate-to-severe COPD: A systematic review and meta-analysis of randomized controlled trials.

Author: AburahmaAhmed, BachuwaGhassan, BanifadelMomen, BarbarawiMahmoud, ChahineAdam, ChandranArul, HamidKewan, HaykalTarek, KheiriBabikir, RashdanLaith, SundusSaira, ZayedYazan

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Triple inhaler therapy (ICS, LAMA, and LABA) was associated with a reduction in moderate-to-severe COPD exacerbations, improved lung function, and improved quality of life when compared to dual inhaler therapy. However, triple therapy was associated with an increased risk of pneumonia.
Paper Details　
Original Abstract of the Article :
INTRODUCTION: Treatment of chronic obstructive pulmonary disease (COPD) is evolving specially with triple inhaler therapy. OBJECTIVES: To perform a meta-analysis to ascertain the safety and efficacy of triple inhaler therapy consisting of an inhaled-glucocorticoid (ICS), long-acting muscarinic anta...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/crj.13026

データ提供：米国国立医学図書館（NLM）

Triple Inhaler Therapy for Moderate-to-Severe COPD: A Comprehensive Evaluation

This research evaluates the [efficacy and safety of triple inhaler therapy] compared to [dual inhaler therapy] for [patients with moderate-to-severe COPD]. The study aims to [determine the benefits and risks of triple inhaler therapy] in improving [lung function, quality of life, and exacerbation rates] in this patient population.

Triple Inhaler Therapy: A Promising Option for COPD Management

The study reveals that [triple inhaler therapy significantly reduced moderate-to-severe COPD exacerbations, improved lung function, and enhanced quality of life compared to dual inhaler therapy], while [increasing the risk of pneumonia]. These findings suggest that [triple inhaler therapy may be an effective treatment option for patients with moderate-to-severe COPD] but that [the potential risks, particularly pneumonia, must be carefully considered].

Optimizing Treatment for COPD: Balancing Benefits and Risks

This research provides valuable insights into the [clinical effectiveness and safety of triple inhaler therapy] for [patients with moderate-to-severe COPD]. The study emphasizes the need for [a careful assessment of individual patient characteristics, risk factors, and potential benefits and risks] to optimize treatment decisions.

Dr. Camel's Conclusion

The journey through the desert of COPD research is often marked by a search for effective and safe treatments. This study, like a weathered camel guiding a caravan through shifting sands, offers valuable insights into the benefits and risks of triple inhaler therapy. It's a reminder that even seemingly simple interventions can have complex consequences, and that careful consideration of individual needs is essential in optimizing patient care. The study highlights the importance of a balanced approach, weighing the potential benefits against the risks, to ensure that each patient receives the most appropriate therapy.
Date :
  1. Date Completed 2020-01-08
  2. Date Revised 2020-01-08
Further Info :

Pubmed ID

30947394

DOI: Digital Object Identifier

10.1111/crj.13026

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.